Comparative study of feline spinal cord tumors for distinction between peripheral nerve sheath tumor and meningioma

Peripheral nerve sheath tumors (PNSTs) and meningiomas in feline spinal canal are sometimes difficult to differentiate solely on the basis of histopathology. In this study, immunohistochemical markers for differentiating PNSTs from meningiomas were investigated. In the control group, non-spinal PNSTs were immunoreactive for S100 and GFAP but not for E-cadherin, whereas intracranial meningiomas were immunoreactive for E-cadherin but not for S100 and GFAP. In the spinal tumor group, 2/7 cases were immunoreactive for S100 and GFAP but not for E-cadherin and were considered PNSTs. In addition, 5/7 cases were immunoreactive for E-cadherin and not for S100 and GFAP and were considered meningiomas. Immunohistochemistry for S100, GFAP and E-cadherin may aid in the differential diagnosis of feline spinal PNSTs and meningiomas.

Authors

Institutions

Publication Details

Journal
Journal of Veterinary Medical Science
Published
2025-01-01
DOI
https://doi.org/10.1292/jvms.25-0082
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative study of feline spinal cord tumors for distinction between peripheral nerve sheath tumor and meningioma

James Chambers, Ryo� Saito, Kazuyuki Uchida
1 links
Journal of Veterinary Medical Science
Neuroblastoma Research and Treatments
article

Comparative study of feline spinal cord tumors for distinction between peripheral nerve sheath tumor and meningioma

James Chambers, Ryo� Saito, Kazuyuki Uchida
article en

Abstract

Peripheral nerve sheath tumors (PNSTs) and meningiomas in feline spinal canal are sometimes difficult to differentiate solely on the basis of histopathology. In this study, immunohistochemical markers for differentiating PNSTs from meningiomas were investigated. In the control group, non-spinal PNSTs were immunoreactive for S100 and GFAP but not for E-cadherin, whereas intracranial meningiomas were immunoreactive for E-cadherin but not for S100 and GFAP. In the spinal tumor group, 2/7 cases were immunoreactive for S100 and GFAP but not for E-cadherin and were considered PNSTs. In addition, 5/7 cases were immunoreactive for E-cadherin and not for S100 and GFAP and were considered meningiomas. Immunohistochemistry for S100, GFAP and E-cadherin may aid in the differential diagnosis of feline spinal PNSTs and meningiomas.

Journal of Veterinary Medical ScienceVol. 87(7)
The University of Tokyo (JP)
Openalex Percentile: Top 83%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.